Newrotex selected for MedTech Innovator 2023 Cohort – the world’s largest MedTech Accelerator

Newrotex are delighted to announce that we have been selected to join the prestigious MedTech Innovator programme. 61 companies were selected from over 1,150 applicants worldwide and the team will kick off in San Francisco next week. CEO Alex Woods “We’re incredibly proud to have been selected for the MedTech Innovator Accelerator programme including the American Society of Plastic Surgeons (ASPS) cohort. It recognises how our regenerative silk technology can help to address the large unmet need for patients to have a robust and effective treatment for nerve injuries”. Read more

Newrotex receive MedTech Innovator Military Pitch Award

Newrotex have been awarded an “Outstanding Pitch” award from the Medical Technology Enterprise Consortium (MTEC) following on from the recent MedTech Innovator Road Tour Pitch Event. MTEC are a consortium focuses on the development of medical solutions that protect, treat, and optimize the health and performance of U.S. military personnel and civilians. Newrotex are delighted to receive this recognition of the huge value our technology can offer to early treatment for injured military personnel and CCO Andrew Elphick will be travelling to Richmond, VA to receive the award at MTEC’s 8th Annual Membership Meeting.

Newrotex receive NIHR i4i FAST Award

Newrotex are delighted to announce that we have successfully received an i4i FAST (Funding at the Speed of Translation) Award form the National Institute for Health and Care Research (NIHR). The award, lead by Chief Science Officer Dr Robyn Plowright, will help Newrotex to develop QMS systems to meet regulatory requirements to bring our technology closer to patients.

Newrotex featured in the Sunday Mirror

Newrotex were pleased to welcome the Sunday Mirror to our office and lab space and to discuss the important work we are doing to bringing our exciting silk technology closer to patients. The full article is found here: EXCLUSIVE: Spider’s silk could be used to repair human nerve damage in ‘exciting’ new treatment

Newrotex invited to attend US MedTech Innovator Road Tour Pitch Event

Dr Alex Woods (CEO) attended the prestigious US MedTech Innovator Road Tour at the East Coast “Pitch Event” in Baltimore, USA last month. Newrotex was selected from over 1100 companies to have the opportunity to present our work to panels of leading opinion leaders from the Medical Device sector; Venture and Strategic investors and with leading Medical experts.  In particular, the East Coast event included representatives from the association of the American Society of Plastic Surgeons (ASPS) as well as extensive participation of experts from the US Military and Medical Technology Enterprise Consortium (MTEC). Initial feedback from the event was extremely positive and we are now awaiting news of our possible progress to the final international awards event.

Research article: luminal silk inside silk tubes for nerve repair

Researchers from MedUni Vienna have published an exciting article today alongside Newrotex Co-Founder Professor Fritz Vollrath. The results, published today in the journal Advanced Healthcare Materials, add even further evidence of the amazing regenerative properties of our technology combining luminal silk fibres from spiders with moth silk tubes for bridging nerve defects. Read more here